Bicarbonated Ringer's Solution Versus Lactated Ringer's Solution in Patients With Septic Shock
Launched by ZHONGNAN HOSPITAL · Jun 23, 2020
Trial Information
Current as of May 20, 2025
Unknown status
Keywords
ClinConnect Summary
Although the latest guidelines recommend crystalloids as the first choice for the patients' fluid resuscitation, it still remains controversial that which crystalloid solution is the best choice. It is reported that balanced crystalloid can result in better outcomes than saline for critically ill patients. However, there are few studies conducted between different crystalloid solutions.
Lactated ringer's solution is the longest-used crystalloid solution. Compared with lactated ringer's solution whose anion is lactate, the anion of bicarbonate ringer's solution is bicarbonate. And lactate n...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. At the age of 18 to 75;
- • 2. Being treated in the ICU;
- • 3. Diagnosed as septic shock according tho the definition of Sepsis 3.0 with fluid resuscitation requirement.
- Exclusion Criteria:
- • 1. Severe hepatic failure;
- • 2. Possible brain injury;
- • 3. With absolute contraindications for central vena catheterization;
- • 4. Ever participated in another clinical trial within 30 days prior enrollment;
- • 5. Have corrected metabolic acidosis through alkaline drug application within 24 hours prior to enrollment;
- • 6. Hypermagnesemia or hypothyroidism;
- • 7. Pregnant of breast-feeding women;
- • 8. Considered inevitable death;
- • 9. Other situations where investigators think enrollment is not appropriate.
About Zhongnan Hospital
Zhongnan Hospital, affiliated with Wuhan University, is a leading medical institution in China renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on multidisciplinary collaboration, the hospital employs state-of-the-art facilities and a team of highly skilled professionals to conduct rigorous clinical studies aimed at improving patient outcomes. Zhongnan Hospital prioritizes ethical standards and patient safety, ensuring adherence to regulatory requirements while fostering a culture of scientific excellence. As a prominent sponsor of clinical trials, the hospital plays a pivotal role in contributing to the global medical community and enhancing the understanding of various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
Wuhan, Hubei, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials